This narrative review aims to synthesize current knowledge on predictive factors influencing the efficacy of ADCs, including key biomarkers, such as HER2 and TROP-2 expression, hormone receptor (HR) status, and the tumor microenvironment. Here, ERBB2 is linked to neoplasm.